相关实验视频
Updated: Sep 13, 2025

06:55
Ileectomy-induced Bile Overaccumulation in Mouse Intestine
Published on: August 21, 2017
9.6K
在小鼠模型中,粘土减轻了由脂肪引起的腹
Shalom Emmanuel1, Nyma Siddiqui1, Ting Du1
1Department of Pharmaceutical Science, College of Pharmacy and Health Sciences, Texas Southern University, 3100 Cleburne Street, Houston, TX 77004, USA.
Metabolites
|July 25, 2025
概括
使用甘三酸盐 (GTO) 开发了一种用于脂肪诱导腹的新小鼠模型. 蒙莫里隆石粘土 (MMT) 通过调节便胆酸和结肠炎症,显著降低了腹的严重程度.
科学领域:
- 胃肠病学 胃肠病学
- 药理学 药理学是指药理学的学科.
- 动物模型 动物模型
背景情况:
- 脂肪引起的腹是一种常见的胃肠道问题.
- 有限的动物模型和治疗方法存在于与脂肪相关的腹.
- 开发有效的模型和疗法对于管理这种情况至关重要.
研究的目的:
- 使用甘三酸盐 (GTO) 建立高脂肪相关腹的小鼠模型.
- 评估蒙特莫里隆尼特粘土 (MMT) 在治疗GTO诱导的腹方面的疗效.
- 调查MMT抗腹作用的潜在机制.
主要方法:
- 一个小鼠模型是通过口服GTO. gavage给药建立的.
- 蒙莫里隆石粘土 (MMT) 用于评估其抗腹性质.
- 进行了便分析,肠道组织组织学检查和便胆酸量化.
主要成果:
- 在2000 mg/kg的GTO管理成功诱导了腹模型.
- 在剂量取决的方式上,MMT显著降低了腹的发病率和严重程度.
- MMT治疗调节了便胆酸水平,减少了结肠炎症.
结论:
- 在创建脂肪诱导腹的小鼠模型时,GTO是有效的.
- 蒙莫里隆石粘土在缓解脂肪引起的腹方面具有显著的潜力.
- MMT的治疗效果与便胆酸的调节和肠道炎症的减少有关.
相关概念视频
Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents
319
Diarrhea is characterized by the occurrence of frequent, watery bowel movements. Various factors can trigger diarrhea, including viral or bacterial infections, foodborne illnesses, side effects from certain medications, and underlying digestive disorders. If not adequately managed, diarrhea can lead to complications such as dehydration, electrolyte imbalances, and nutrient deficiencies. Severe diarrhea can lead to significant weight loss, malnutrition, and weakened immune function.
Adsorbents...
Adsorbents...
319
Drugs for Treatment of Diarrhea-Predominant IBS
299
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
299

